Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Announces its 5th Annual Cannabis Sciences Virtual Event, Featuring a New "Hot Topics" Track Covering Psychedelics and THC Isomers, Scheduled on March 23, 2022
  • USA - English

The online conference comprises over 15 educational presentations rounding out the one-day comprehensive agenda


News provided by

Labroots

Mar 17, 2022, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Cannabis Sciences Virtual Event, March 23, 2022
Cannabis Sciences Virtual Event, March 23, 2022

YORBA LINDA, Calif., March 17, 2022 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, today announced Cannabis Sciences 2022, hosted on March 23rd with an exceptional lineup of prominent experts spanning sessions including, Medical Cannabis – Therapeutic Updates, The Evolving Regulatory Landscape, Analytical Testing and Automation, Advancements in Cultivation and Extraction Methods, and Hot Topics.

Entering its 5th consecutive year, the free, online event continues to raise the bar for showcasing scientific discoveries and enlightening discussions of cannabis on a global front. This year, the overarching theme of the event is "Cannabis and Hemp Changing the Global Future," bringing together thousands of research scholars, leading academic and industry professionals, scientists, instrument manufacturers, physicians, laboratory experts to learn about the latest advancements in the evolving field of cannabis science.

The conference agenda will headline two stellar keynote addresses by Dr. Dustin Sulak, Founder and Medical Director, Integr8 Health and Co-founder of Healer.com, and Dr, Jeff Chen, Chief Executive Officer and Co-founder of Radicle Science. Dr. Sulak will summarize the preclinical findings on acidic cannabinoids and provide practical strategies for clinicians and patients to take advantage of the power of raw cannabis during his talk titled, "Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics," followed by live Q&A. Next, Dr. Jeff Chen will discuss current knowledge of the therapeutic potential of CBD and evaluate the current regulatory landscape as well during his presentation titled, "Preliminary Results from the Radicle Science ACES Study, History's Largest Longitudinal Trial of CBD Products, with live Q&A.

Dr. Dustin Sulak, Founder and Medical Director, Integr8 Health and Co-founder of Healer.com said, "Cannabis is a well-known treasure chest of medicinal compounds with therapeutic potential. Surprisingly, some of its most abundant constituents, the acidic cannabinoids, have long been overlooked and dismissed as inactive precursors. My clinical experience and the scientific literature have both shown that these compounds are far from inactive, and in fact have valuable therapeutic effects. THCA and CBDA have some overlapping and other distinct properties when compared to their more well-known counterparts, THC and CBD, but most people don't know how to take advantage of these non-impairing cannabinoids. I'm excited to share a review of the literature and practical how-to-use tips with the Labroots audience so more people can access the power of raw cannabis."

Dr. Jeff Chen, Founder and Former Executive Director of the UCLA Cannabis Research Initiative, and Co-founder/CEO of Radicle Science stated, "Non-prescription cannabinoids are currently being used by as many as 50 million Americans, yet due to nearly a century of regulatory restrictions that continue to this day, we have little clinical trial data on their effectiveness. Via Labroots' virtual platform, I'm excited to highlight Radicle Science's unique virtual direct-to-consumer clinical trials approach and discuss the recent results of our ACES (Advancing CBD Education & Science) study--the largest clinical trial of non-prescription CBD products in history involving nearly 3,000 Americans across all 50 states.

Rounding out the full day, attendees will explore topics such as debunking myths and misconceptions of the psychedelics industry, the use of polysaccharide-based chiral stationary phases for the achiral and chiral separation of cannabinoids, liquid chromatography - tandem mass spectrometry discovery and profiling of anthocyanin flavonoids in cannabis, struggling to follow the USDA's new hemp testing rules: LIMS makes it easy, overcoming challenges associated with analysis of pesticides regulated by Colorado state in hemp using a novel LC/MS/MS method with dual ESI and APCI source, microbe ubiquity: the myth of sterile cultivation systems, naming just a few.

"We are thrilled to host our 5th Cannabis Sciences virtual event highlighting such renowned presenters bringing cutting-edge science to the forefront," said Greg Cruikshank, Chief Executive Officer of Labroots. "Labroots continues its solid tradition of featuring the latest trends in cannabis therapeutics as well as advances in hemp science, and we look forward to sharing these discoveries, medical research, novel approaches, and regulations with the scientific community as we shape the future of the cannabis industry."

Produced on Labroots' interactive platform while connecting across all desktop and mobile devices, the online environment provides a one-stop collaboration encompassing a lobby with leaderboard and gamification, auditorium featuring live-streaming video webcasts and live chats during scheduled presentations, poster hall to explore data and also engage in live chats, exhibit hall, and a networking lounge to connect with colleagues including a social media wall and photo booth all providing an enriched learning experience for all attendees. Participants can earn one Continuing Education credit (per presentation) for a maximum of 40 credits.

For more information or to register for the event free of cost, click here. Use #LRcannabis to follow the conversation online!

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected]

Twitter

SOURCE Labroots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.